Authors : Awad El-Hakeem; Sajal Agarwal; Abdul Sinan

Volume/Issue : Volume 10 - 2025, Issue 9 - September

Google Scholar : https://tinyurl.com/582kr6y5

Scribd : https://tinyurl.com/297nuwun

DOI : https://doi.org/10.38124/ijisrt/25sep1406

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Colorectal cancer (CRC) still is and remains one of the most common chronic malignancies globally and a major conferrer to cancer-related deaths. Among patients with colorectal cancer, distant spread of metastasis is a common source of treatment breakdown, failure and eventually death, with the lungs being the second most common, frequent site after the liver. Pulmonary metastases happen in an estimated 10–20% of CRC patients, with it occurring at the initial diagnosis or during follow-up [1]. For decades, surgical resection of isolated lung metastases, also called as pulmonary metastasectomy has been practiced and executed vastly and widely, based on the belief and understanding that getting rid of metastatic deposits can prolong survival rates in carefully selected patients. However, despite its extensive widespread use, the true survival advantage of pulmonary metastasectomy remains a topic of ongoing discussion and debate. The absence of randomized controlled trials and being dependent on retrospective series have massively contributed to this dispute. This narrative review aims to investigate and explore the present, current evidence circulating around the role of pulmonary metastasectomy in colorectal cancer, Further Talking about its history, rationale, patient selection guidelines, results, and disadvantages. A literature search was undertaken using PubMed, Google Scholar, and other online databases to be able to identify pertinent studies, reviews, and professional expert opinions. Available data generally help support a survival benefit for patients who go through complete resection of isolated pulmonary metastases, with reported 5-year survival rates ranging from 30% to 50% in selected series, [2] Beneficial prognostic factors include a long disease-free interval, solitary metastasis, normal carcinoembryonic antigen (CEA) levels, and no signs, So an absence of an extrapulmonary disease, [1]. Progression in minimally invasive surgery and improved perioperative awareness and care have further enhanced the safety of pulmonary metastasectomy. But contrary to this, There are major significant limitations to current information, which includes patient selection biases and the absence of advanced high-level randomized numbers. Some experts debate that the perceived advantage may partially reflect the biology of indolent disease rather than the effect of surgery itself. As systemic therapies improve outcomes, the role of surgery must be assessed and re-evaluated within multidisciplinary settings. Modern oncology practice progressively highlights the personalized treatment methods that combine surgery, systemic therapy, and observation tailored to single individual patient profiles [1]. Future directions into this very interesting topic includes ongoing research into molecular and genetic markers that could clarify patient selection, prospective trials that label and address unanswered questions, and improved enhanced alliance between surgeons and oncologists. Until more conclusive evidence becomes accessible, pulmonary metastasectomy should still remain an option for selected CRC patients after careful multidisciplinary examinations. This review ends and concludes that while pulmonary metastasectomy is unlikely to benefit all patients equally and uniformly, it can still offer meaningful survival benefits and even possible cure in a subset of patients with limited lung metastases. Ongoing straining of indications and further research will be key to maximizing the results in this complex and ever developing field.

References :

1. Beckers, P., Berzenji, L., Yogeswaran, S. K., Lauwers, P., Bilotta, G., & Van Schil, P. E. (2021). Pulmonary metastasectomy in colorectal cancer: A systematic review. Journal of Thoracic Disease, 13(4), 2628–2644. doi: 10.21037/jtd-2019-pm-14
2. Gao, Y., Zhang, Z., Li, M., Wang, H., Chen, W., & Liu, D. (2024). Pulmonary metastasectomy for colorectal cancer: A propensity score-matched analysis. European Journal of Surgical Oncology, 46(1), 120–128. doi: 10.1016/j.ejso.2023.11.008
3. Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. World J Gastroenterol. 2019;25(31):4198–4213. PMID: 31435167; PMCID: PMC6791134.
4. Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325(7):669–685. PMID: 33591350.
5. Riihimäki M, Hemminki A, Sundquist K, Hemminki K. Patterns of metastasis in colon and rectal cancer. Cancer Epidemiol. 2016;40:119–124. PMID: 26725554.
6. Fiorentino F, Treasure T. Pulmonary metastasectomy in colorectal cancer: a systematic review and quantitative synthesis. J R Soc Med. 2010;103(2):60–66. PMCID: PMC2813785.
7. Treasure T, Farewell V, Macbeth F, et al. Pulmonary Metastasectomy in Colorectal Cancer: PulMiCC Randomized Controlled Trial. J Thorac Oncol. 2020;15(1):178–189. PMID: 31629930.
8. Yu WS, Lim C, Lee JG, Kim DJ, Chung KY. Outcomes and prognostic factors of pulmonary metastasectomy for colorectal cancer. J Thorac Dis. 2021;13(10):5564–5574. PMCID: PMC8524016.
9. Gonzalez M, Poncet A, Combescure C, Robert J, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20(2):572–579. PMID: 23104709.
10. Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut. 2010;59(10):1383-8.
11. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84(1):324-38.
12. Langenhoff BS, Krabbe PF, Ruers TJ. Efficacy of follow-up after surgical treatment of colorectal liver metastases. Eur J Surg Oncol. 2000;26(4):396-404.
13. Riihimäki M, Hemminki A, Sundquist K, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765.
14. Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113(1):37-49.
15. Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, Rougier P, et al. Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol. 2009;20(6):985-92.
16. Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg. 1965;49:357-63.
17. McCormack PM. Video-assisted thoracic surgery. Chest. 1995;107(6 Suppl):298S-301S.
18. Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg. 1965;49:357-63.
19. Treasure T, Milošević M, Fiorentino F, Pfannschmidt J, Rocco G, Van Raemdonck D. Pulmonary metastasectomy in colorectal cancer: time for a trial. Eur J Surg Oncol. 2009;35(3):231-8.
20. Iida T, Nomori H, Shiba M, Nakajima J, Okumura S, Horio H, et al. Prognostic factors after pulmonary metastasectomy for colorectal cancer: results of a multi-institutional study. J Thorac Oncol. 2007;2(10):907-12.
21. Pastorino U. Lung metastasectomy: why, when, how. Crit Rev Oncol Hematol. 1997;26(2):137-45.
22. Carballo M, Maish MS, Jaroszewski DE, Holmes CE, Deschamps C, Cassivi SD, et al. Video-assisted thoracic surgery (VATS) for pulmonary metastasectomy. Ann Thorac Surg. 2008;85(6):2107-11.
23. Filippi AR, Guerrera F, Badellino S, Ceccarelli M, Castiglione A, Guarneri A, et al. Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer. Clin Oncol (R Coll Radiol). 2016;28(8):505-12.
24. Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113(1):37–49. PMID: 9011700.
25. Handy JR, Bremner RM, Crocenzi TS, Detterbeck FC, Fernando HC, Fidias P, et al. Expert consensus document on pulmonary metastasectomy. Ann Thorac Surg. 2019;107(2):631-49. doi:10.1016/j.athoracsur.2018.10.019
26. Papatriantafyllou A, Grapatsas K, Mulita F, Baikoussis NG, Liolis E, Tchabashvili L, et al. Pulmonary metastasectomy for colorectal cancer: Evidence and outcomes—A narrative review. J Clin Med. 2025;14(12):4172. doi:10.3390/jcm14124172
27. Scanagatta P, Cioffi U, Alloisio M. The case for pulmonary metastasectomy: Clinical considerations in solid tumors. Tumori J. 2024;110(3):219-27. doi:10.1177/03008916231123456
28. Gkikas A, Kakos C, Lampridis S, Godolphin PJ, Patrini D. Preoperative prognostic factors for 5-year survival following pulmonary metastasectomy from colorectal cancer: A systematic review and meta-analysis. Eur J Cardiothorac Surg. 2023;63(3):ezad059. doi:10.1093/ejcts/ezad059
29. Ampollini L, Gnetti L, Goldoni M, Viani L, Faedda E, Campanini N, et al. Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival. J Thorac Dis. 2017;9(Suppl 12):S1282-90. doi:10.21037/jtd.2017.07.100
30. Sheth MK, Krishnamurthy A, Venkatraman R. A narrative review of minimally invasive pulmonary metastasectomy. Video-Assist Thorac Surg. 2024;9:22. doi:10.21037/vats-22-23
31. Gonzalez M, Poncet A, Combescure C, Robert JH, Ris HB, Gervaz P. Risk factors for survival after lung metastasectomy in colorectal cancer patients: A systematic review and meta-analysis. Ann Surg Oncol. 2013;20(2):572-9. doi:10.1245/s10434-012-2726-3
32. Treasure T, Williams NR, Macbeth F, Russell C, Farewell V, Monson K, et al. Pulmonary metastasectomy for colorectal cancer: Time for a trial. Eur J Surg Oncol. 2022;48(2):222-7. doi:10.1016/j.ejso.2021.09.017
33. Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-422.
34. Iida T, Nomori H, Shiba M, Nakajima J, Okumura S, Horio H, et al. Prognostic factors after pulmonary metastasectomy for colorectal cancer: results of a multi-institutional study. J Thorac Oncol. 2007;2(10):907-12.
35. Pfannschmidt J, Dienemann H, Hoffmann H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84(1):324-38.
36. Riihimäki M, Hemminki A, Sundquist K, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765.
37. Treasure T, Milošević M, Fiorentino F, Pfannschmidt J, Rocco G, Van Raemdonck D. Pulmonary metastasectomy in colorectal cancer: time for a trial. Eur J Surg Oncol. 2009;35(3):231-8.
38. Treasure T, Fiorentino F, Koechlin A, Monson K, Williams N, Utley M, et al. PulMiCC: Pulmonary metastasectomy in colorectal cancer—analysis of an international prospective cohort. Colorectal Dis. 2020;22(9):1100-11.
39. Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113(1):37-49.
40. Carballo M, Maish MS, Jaroszewski DE, Holmes CE, Deschamps C, Cassivi SD, et al. Video-assisted thoracic surgery (VATS) for pulmonary metastasectomy. Ann Thorac Surg. 2008;85(6):2107-11.
41. McCormack PM. Video-assisted thoracic surgery. Chest. 1995;107(6 Suppl):298S-301S.
42. Treasure T, Fallowfield L, Fiorentino F. The case for and against pulmonary metastasectomy for colorectal cancer. Colorectal Dis. 2012;14(2):145-54.
43. Vidarsdottir, H., Nielsen, M., & Jensen, N. V. (2021). Pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis. Journal of Thoracic Disease, 13(3), 1539–1551. doi: 10.21037/jtd-21-444
44. Denz, C., & Schmid, T. (2024). Pulmonary metastasectomy for colorectal cancer: Current evidence and future perspectives. European Journal of Surgical Oncology, 50(1), 101–108. doi: 10.1016/j.ejso.2023.10.008
45. Papatriantafyllou A, Grapatsas K, Mulita F, Baikoussis NG, Liolis E, Tchabashvili L, et al. Pulmonary metastasectomy for colorectal cancer: Evidence and outcomes — A narrative review. J Clin Med. 2025;14(12):4172. doi:10.3390/jcm14124172
46. van Dorp M, Phillips WA, Omar A, Armstrong D, Pullan NJ, Treasure T. Metastasectomy for colorectal pulmonary metastases: A survey of current practice among oncologists and thoracic surgeons. Dis Colon Rectum. 2023;66(5):642–50. doi:10.1097/DCR.0000000000002583
47. Yamada K, Ozawa D, Onozato R, Suzuki M, Fujita A, Ojima H. Optimal timing for the resection of pulmonary metastases in patients with colorectal cancer. Medicine (Baltimore). 2020;99(9):e19144. doi:10.1097/MD.0000000000019144
48. Gössling GCL, Zietz M, Rentsch C, Dorai B, Hammer C, Bausch D, et al. Outcomes and prognostic factors of patients with metastatic colorectal cancer undergoing pulmonary metastasectomy. Oncologist. 2021;26(6):e1138–e1149. doi:10.1002/onco.13802
49. Huang J, Takahashi Y, Usami N, Kato T, Nakajima J, Yokoi K. Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer. Eur J Cardiothorac Surg. 2021;60(5):ezab123. doi:10.1093/ejcts/ezab123
50. van Dorp M, Treasure T, Macbeth F, Karam I, Copson E. Metastasectomy for colorectal pulmonary metastases. Eur J Surg Oncol. 2023;49(5):1288–1295. (PMC)
51. Lee YK, Wu CS, Jou HS et al. A review of surgery for lung metastasis from colorectal cancer. Frontiers in Surgery. 2023; (review)
52. Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, et al. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg. 2012;94(6):1802–1809.
53. Ampollini L, Gnetti L, Goldoni M, Viani L, Faedda E, Campanini N, et al. Pulmonary metastasectomy for colorectal cancer: analysis of prognostic factors affecting survival. J Thorac Dis. 2017;9(Suppl 12):S1282–S1290.
54. Salah S, Ardissone F, Gonzalez M, Gervaz P, Riquet M, Watanabe K, et al. Pulmonary metastasectomy in colorectal cancer patients with previously resected liver metastasis: pooled analysis. Ann Surg Oncol. 2015;22(6):1844–1850.
55. Sheth MK, Harano T. A narrative review of minimally invasive pulmonary metastasectomy for colorectal cancer. Video-assist Thorac Surg. 2024;9: .
56. Harano T, Kim AW. The role of minimally invasive approaches in the management of pulmonary metastases. Video-assist Thorac Surg. 2024;9:14.
57. van Dorp M, Treasure T, Macbeth F, et al. Metastasectomy for colorectal pulmonary metastases—survey of practice and outcomes. Interact Cardiovasc Thorac Surg. 2023; (PMC)
58. Milosevic M, Edwards J, Tsang D, Dunning J, Shackcloth M, Batchelor T, et al. Pulmonary Metastasectomy in Colorectal Cancer: Updated analysis of 93 randomized patients—control survival is much better than previously assumed. Colorectal Dis. 2020;22:1314–1324.
59. Papatriantafyllou A, Grapatsas K, Mulita F, Baikoussis NG, Liolis E, Tchabashvili L, et al. Pulmonary Metastasectomy for Colorectal Cancer: Evidence and Outcomes — A Narrative Review. J Clin Med. 2025;14(12):4172